Recent 8-K filings for CHE

• May 19, 2026, 10:43 AM ET other material materiality 0.15 negative item 5.07

  Chemed say-on-pay fails at annual meeting; 61% votes against

  Non-binding executive compensation proposal rejected: 4,383,683 For vs 6,926,656 Against (61.3% against).

• April 23, 2026, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01 ◈ Earnings Releases

  Chemed Q1 adjusted EPS $5.65; boosts 2026 guidance to $24.00-$24.75 on VITAS momentum

  GAAP diluted EPS $4.84, down 0.4% YoY; adjusted EPS $5.65, up 0.4% YoY.

• April 13, 2026, 7:59 PM ET debt materiality 0.40 neutral item 1.01item 10.1item 2.03item 9.01 ◈ Debt Financings◈ Material Agreements

  Chemed renews $450M senior secured credit facility for five years

  Five-year $450M revolving credit facility includes $100M letters of credit.

• February 25, 2026, 6:59 PM ET earnings materiality 0.75 negative item 2.02item 9.01

  Chemed Q4 2025 GAAP EPS down 9%, Roto-Rooter segment weak; guidance for 2026 growth

  Revenue $639.3M flat YoY; GAAP diluted EPS $5.48 (-9%), adjusted EPS $6.42 (-6%).

• October 28, 2025, 7:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  Chemed Q3 GAAP EPS falls 10.8% to $4.46; adjusted EPS down 6.6% to $5.27

  Consolidated revenue $624.9M (+3.1% YoY); VITAS revenue $407.7M (+4.2%), Roto-Rooter $217.2M (+1.1%).

• July 29, 2025, 7:59 PM ET earnings materiality 0.85 negative item 2.02item 5.02item 9.01

  Chemed Q2 adjusted EPS $4.27 (-21.9% YoY); cuts FY2025 guidance; VITAS CEO departs

  GAAP EPS $3.57 (-23.2%); adjusted EPS $4.27 (-21.9%); revenue $618.8M (+3.8%).

• June 27, 2025, 7:59 PM ET earnings materiality 0.85 negative item 7.01item 9.01

  Chemed projects $18-25M Medicare Cap hit; lowers FY2025 guidance

  VITAS expects $18M-$25M Medicare Cap revenue limit for Florida consolidated program (excl. Tallahassee) in 2025 Cap Year.

• May 20, 2025, 7:59 PM ET other materiality 0.15 neutral item 5.07

  Chemed shareholders elect all director nominees, approve 2025 stock plan and advisory compensation at annual meeting

  All nine director nominees elected; Kevin McNamara received 12,805,746 for vs 203,421 against.

• April 23, 2025, 7:59 PM ET earnings materiality 0.70 neutral item 2.02item 9.01

  Chemed Q1 revenue up 9.8% to $646.9M; GAAP EPS $4.86, adjusted $5.63

  VITAS net revenue +15.1% to $407.4M; ADC 22,244 (+13.1%); adjusted EBITDA $70.3M (+15.9%).

• February 26, 2025, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Chemed Q4 2024 revenue up 9.2% to $640M; adj. EPS $6.83; guides FY2025 adj. EPS $24.95-$25.45

  GAAP diluted EPS $6.02 (+2.0% YoY); adjusted diluted EPS $6.83 (+3.5% YoY).

• October 29, 2024, 7:59 PM ET earnings materiality 0.80 negative item 2.02item 9.01

  Chemed Q3: rev $606M (+7.4%), adj EPS $5.64; FY2024 adj EPS guidance cut to $23.00-$23.15 on Roto-Rooter weakness

  GAAP diluted EPS $5.00 (+1.4%); adjusted diluted EPS $5.64 (+6.0%).

• July 24, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  Chemed Q2 adjusted EPS $5.47 (+34.1% YoY); raises FY2024 guidance to $23.55-$23.80

  Revenue $595.9M (+7.6%); GAAP EPS $4.65 (+32.5%); adjusted EPS $5.47 (+34.1%).

• May 21, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.07

  Chemed annual meeting elects directors, approves PwC and say-on-pay, rejects termination pay proposal

  All 10 director nominees elected; Kevin McNamara received 13.3M votes for, Patrick Grace 10.3M.

• April 24, 2024, 7:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01 ◈ Earnings Releases

  Chemed Q1 2024: Adjusted EPS $5.20 beats; VITAS EBITDA surges 67%, Roto-Rooter down 16%

  Revenue +5.2% to $589.2M; GAAP EPS $4.24 (+18.4%); Adjusted EPS $5.20 (+21.5%)

• April 17, 2024, 7:59 PM ET M&A materiality 0.65 positive item 2.01 ◈ M&A Transactions

  VITAS completes $85M acquisition of Covenant hospice operations in Florida and Alabama

  Purchased substantially all hospice operations and an assisted living facility from Covenant for $85M in cash.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.75 · Most common event earnings

5 positive 6 negative 4 neutral

source · CHE on sec.gov